Pier Capital’s Allergan Inc AGN Stock Holding History

Pier Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-844	Closed	-$71K	–	188
2013 Q2	$71K	Buy	+844	New	+$87.6K	0.01%	113

Other funds holding AGN

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pier Capital's AGN Position: Q3 2013 in Review

Pier Capital sold out of Allergan Inc (AGN) in Q3 2013, closing a stake of 844 shares — an estimated $71K sold.

Pier Capital first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $71K in Q2 2013. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

Pier Capital reported no remaining Allergan Inc position as of Q3 2013 after selling out during the quarter.
Pier Capital sold 844 Allergan Inc shares in Q3 2013, an estimated $71K.
Pier Capital first reported a position in Allergan Inc in Q2 2013 and held it in 1 quarter.
Pier Capital's Allergan Inc position peaked at $71K in Q2 2013.
642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on Pier Capital's 13F filing for Q3 2013, filed 13 Nov 2013.